Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system

Anette L. Eilertsen*, Sigurd Liestol, Marie-Christine Mowinckel, H. Coen Hemker, Per-Morten Sandset

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    Original languageEnglish
    Pages (from-to)938-943
    Number of pages6
    JournalThrombosis and Haemostasis
    Issue number6
    Publication statusPublished - 2007

    Cite this